Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

511397

registered interest
date	12/04/2016
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Hepatitis
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, pursuant to the Answer of 8 January 2016 to Question 20586, for what reasons the draft Hepatitis C Improvement Framework has been withdrawn.
tabling member constituency	Oxford East
tabling member printed	Mr Andrew Smith
uin	33576
answer	answer is ministerial correction date of answer 20/04/2016 answer text <p>The Department continues working with Public Health England (PHE) and NHS England to advance the public health ambitions set out in the initial framework to establish a strategic approach to tackle hepatitis C.</p><p> </p><p>Both PHE and NHS England are fully committed to improving hepatitis C outcomes including the long-term reduction in transmission of the virus in which treatment has a potentially major role to play.</p><p> </p><p>NHS England has been working on plans for access to treatment during 2016/17 and has committed to produce an operational framework for the treatment of hepatitis C during 2016/17. This will set out NHS England’s commitment to improving outcomes in hepatitis C across England.</p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 33575 question first answered 20/04/2016 13:26:21 answering member 3918 label Biography information for Jane Ellison
tabling member	95 label Biography information for Mr Andrew Smith

511398

registered interest
date	12/04/2016
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Hepatitis
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, pursuant to the Answer of 8 January 2016 to Question 20586, what discussions his Department has had with NHS England on achieving the aims of the draft Hepatitis C Improvement Framework and the decision to withdraw that draft framework.
tabling member constituency	Oxford East
tabling member printed	Mr Andrew Smith
uin	33575
answer	answer is ministerial correction date of answer 20/04/2016 answer text <p>The Department continues working with Public Health England (PHE) and NHS England to advance the public health ambitions set out in the initial framework to establish a strategic approach to tackle hepatitis C.</p><p> </p><p>Both PHE and NHS England are fully committed to improving hepatitis C outcomes including the long-term reduction in transmission of the virus in which treatment has a potentially major role to play.</p><p> </p><p>NHS England has been working on plans for access to treatment during 2016/17 and has committed to produce an operational framework for the treatment of hepatitis C during 2016/17. This will set out NHS England’s commitment to improving outcomes in hepatitis C across England.</p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 33576 question first answered 20/04/2016 13:26:21 answering member 3918 label Biography information for Jane Ellison
tabling member	95 label Biography information for Mr Andrew Smith

511399

registered interest
date	12/04/2016
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Hepatitis
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how many people with hepatitis C commenced treatment in (a) England and (b) each Operational Delivery Network area between 1 April 2015 and 31 March 2016.
tabling member constituency	Oxford East
tabling member printed	Mr Andrew Smith
uin	33577
answer	answer is ministerial correction date of answer 20/04/2016 answer text <p>Information on patient treatment is ordinarily documented in the detailed patient records held by service providers, and not held centrally by NHS England.</p><p> </p><p>For the period 1 April 2015 – 31 March 2016, based on information supplied by clinicians treating people with chronic hepatitis, NHS England estimate that 5,895 patients started treatment.</p><p> </p><p>Operational Delivery Networks (ODNs) were launched in August 2015 and therefore data by ODN as requested (1 April 2015 to 31 March 2016) are not held.</p> answering member constituency Battersea answering member printed Jane Ellison question first answered 20/04/2016 15:58:38 answering member 3918 label Biography information for Jane Ellison
tabling member	95 label Biography information for Mr Andrew Smith

438961

registered interest
date	16/12/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Hepatitis
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how many patients have started treatment under NHS England's commissioning policy for the treatment of cirrhosis in adults with hepatitis C.
tabling member constituency	Oxford East
tabling member printed	Mr Andrew Smith
uin	20470
answer	answer is ministerial correction date of answer 11/01/2016 answer text <p>At 10 November 2015, NHS England had received 2,667 applications to treat from clinicians. Applications relate to patients who either meet NHS England’s commissioning policy for the treatment of hepatitis C patients with cirrhosis or who meet the National Institute for Health and Care Excellence Technology Appraisal guidance for sofosbuvir and simeprevir. The number of applications is likely to be slightly higher than the number starting treatment, as some patients may have decided not to proceed. NHS England expects to have an automated system in place by April 2016 to collect data on treatment referrals and treatment history, including clinical outcome data.</p> answering member constituency Battersea answering member printed Jane Ellison question first answered 11/01/2016 15:03:13 answering member 3918 label Biography information for Jane Ellison
tabling member	95 label Biography information for Mr Andrew Smith

438962

registered interest
date	16/12/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Liver Diseases
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how much has been spent on NHS England's commissioning policy for the treatment of cirrhosis in adults with hepatitis C.
tabling member constituency	Oxford East
tabling member printed	Mr Andrew Smith
uin	20471
answer	answer is ministerial correction date of answer 11/01/2016 answer text <p>NHS England is not in a position to confirm spend to date on the treatment of cirrhosis in adults with hepatitis C. The overall spend will be impacted by the commercial in confidence agreements that are in place with a number of pharmaceutical companies as well as confirmation that patients treated have completed their course. NHS England will be in a position to confirm overall spend on hepatitis C as a result of the commissioning policy and National Institute for Health and Care Excellence guidance at the end of the financial year.</p> answering member constituency Battersea answering member printed Jane Ellison question first answered 11/01/2016 18:04:02 answering member 3918 label Biography information for Jane Ellison
tabling member	95 label Biography information for Mr Andrew Smith

438963

registered interest
date	16/12/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Hepatitis
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what funding is earmarked to support treatment for hepatitis C in 2016.
tabling member constituency	Oxford East
tabling member printed	Mr Andrew Smith
uin	20472
answer	answer is ministerial correction date of answer 07/01/2016 answer text <p>NHS England is in the process of finalising allocations for its commissioning functions. A budget for hepatitis C will be set as part of the overarching 2016/17 planning process for specialised commissioning. This will be done in line with the national planning guidance and timetable which is due to be announced shortly.</p> answering member constituency Battersea answering member printed Jane Ellison question first answered 07/01/2016 11:38:31 answering member 3918 label Biography information for Jane Ellison
tabling member	95 label Biography information for Mr Andrew Smith

438984

registered interest
date	16/12/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Hepatitis
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what estimate NHS England has made of how many patients will commence treatment for hepatitis C in 2016.
tabling member constituency	Oxford East
tabling member printed	Mr Andrew Smith
uin	20469
answer	answer is ministerial correction date of answer 06/01/2016 answer text <p>NHS England and the 22 Operational Delivery Networks are working together to discuss the implications for planned treatment during 2016/17 of the recently published National Institute for Health and Care Excellence Technology Appraisals for three new oral treatments (Sofosbuvir + Ledispasvir; Daclatasvir; Paritaprevi/ritonavir/ Ombitasvir+/-dasabuvir).</p><br /><p>These appraisals recommend access (depending on hepatitis C genotype and cirrhosis status) for patients where treatment and prescribing decisions are made by multidisciplinary teams in the operational delivery networks, and where patients have been prioritised for treatment based on highest unmet clinical need. This work will continue over the next two months and we will have a better idea of the number of patients later this financial year.</p> answering member constituency Battersea answering member printed Jane Ellison question first answered 06/01/2016 12:41:51 answering member 3918 label Biography information for Jane Ellison
tabling member	95 label Biography information for Mr Andrew Smith

433215

registered interest
date	30/11/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Dementia
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what assessment he has made of the effect of changes to local government funding on the delivery of the National Dementia Strategy.
tabling member constituency	Oxford East
tabling member printed	Mr Andrew Smith
uin	18181
answer	answer is ministerial correction date of answer 08/12/2015 answer text <p>On 21 February 2015, the Prime Minister launched his new Challenge on Dementia 2020, which builds on the achievements of the Prime Minister’s challenge on dementia 2012-2015. It sets out the vision for dementia care, support, awareness and research to be transformed by 2020.</p><br /><p>Local authorities as well as clinical commissioning groups are responsible for funding and commissioning services based on their local population's needs and ensuring that the services they secure provide the best quality for local people.</p><br /><p>As part of the Spending Review, the Government announced that councils will be able to introduce a new social care precept. The social care precept gives local authorities that are facing significant pressures the freedom to raise council tax to help mitigate against these pressures. It puts money raising powers into the hands of local areas who best understand the need in their area and who are best placed to respond.</p><br /><p>Further, the Spending Review set out the Government’s commitment to fund a Dementia Research Institute.</p><br /> answering member constituency Battersea answering member printed Jane Ellison question first answered 08/12/2015 17:11:12 answering member 3918 label Biography information for Jane Ellison
tabling member	95 label Biography information for Mr Andrew Smith

422269

registered interest
date	19/10/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Sugar
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, when he expects Public Health England's Evidence into Action review of the evidence on reducing sugar consumption to be published.
tabling member constituency	Oxford East
tabling member printed	Mr Andrew Smith
uin	12288
answer	answer is ministerial correction date of answer 27/10/2015 answer text <p>There are no plans to introduce a tax on sugar-sweetened drinks. However all taxes are kept under review, with decisions being a matter for the Chancellor as part of the Budget process.</p><br /><p>Public Health England's (PHE) report <em>Sugar Reduction: The evidence for action</em> was published on the GOV.UK website on 22 October. We continue to work very closely with PHE and this evidence is integral to our ongoing policy development. We will publish our childhood obesity strategy in the new year.</p><br /><p><em>Sugar Reduction: The evidence for action</em> is available at:</p><br /><p><a href="http://www.gov.uk/government/uploads/system/uploads/attachment_data/file/470179/Sugar_reduction_The_evidence_for_action.pdf" target="_blank">www.gov.uk/government/uploads/system/uploads/attachment_data/file/470179/Sugar_reduction_The_evidence_for_action.pdf</a></p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 12287 question first answered 27/10/2015 15:42:56 answering member 3918 label Biography information for Jane Ellison
tabling member	95 label Biography information for Mr Andrew Smith

422270

registered interest
date	19/10/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Sugar: Taxation
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, if he will make an assessment of the potential of introducing tax on sugar-sweetened drinks to improve liver disease health outcomes in England.
tabling member constituency	Oxford East
tabling member printed	Mr Andrew Smith
uin	12287
answer	answer is ministerial correction date of answer 27/10/2015 answer text <p>There are no plans to introduce a tax on sugar-sweetened drinks. However all taxes are kept under review, with decisions being a matter for the Chancellor as part of the Budget process.</p><br /><p>Public Health England's (PHE) report <em>Sugar Reduction: The evidence for action</em> was published on the GOV.UK website on 22 October. We continue to work very closely with PHE and this evidence is integral to our ongoing policy development. We will publish our childhood obesity strategy in the new year.</p><br /><p><em>Sugar Reduction: The evidence for action</em> is available at:</p><br /><p><a href="http://www.gov.uk/government/uploads/system/uploads/attachment_data/file/470179/Sugar_reduction_The_evidence_for_action.pdf" target="_blank">www.gov.uk/government/uploads/system/uploads/attachment_data/file/470179/Sugar_reduction_The_evidence_for_action.pdf</a></p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 12288 question first answered 27/10/2015 15:42:56 answering member 3918 label Biography information for Jane Ellison
tabling member	95 label Biography information for Mr Andrew Smith